Organogenesis enters $75M at-the-market equity distribution agreement with BTIG and Citizens JMP

Organogenesis Holdings Inc.

Up to $75M of Class A common stock may be sold from time to time through BTIG and Citizens JMP Securities.
Agents receive a 3% commission on the gross sales price per share sold under the agreement.
Company has no obligation to sell any shares; sales are at its discretion based on market conditions.
Shares will be sold on Nasdaq Capital Market via at-the-market offerings under Rule 415(a)(4).
Agreement includes customary indemnification; terminates upon termination per its terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.